Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia

por Báez-Gutiérrez, Nerea, Rodríguez-Ramallo, Héctor, Moreno, María Antonia-Pérez, Arboli, Eduardo-Rodriguez, Abdel-kader Martín, Laila
Publicado 2021

Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries

por Récher, Christian, Röllig, Christoph, Bérard, Emilie, Bertoli, Sarah, Dumas, Pierre-Yves, Tavitian, Suzanne, Kramer, Michael, Serve, Hubert, Bornhäuser, Martin, Platzbecker, Uwe, Müller-Tidow, Carsten, Baldus, Claudia D., Martínez-Cuadrón, David, Serrano, Josefina, Martínez-Sánchez, Pilar, Arbolí, Eduardo Rodríguez, Gil, Cristina, Bergua, Juan, Bernal, Teresa, de la Fuente Burguera, Adolfo, Delabesse, Eric, Bidet, Audrey, Pigneux, Arnaud, Montesinos, Pau
Publicado 2021

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registr...

por Bérard, Emilie, Röllig, Christoph, Bertoli, Sarah, Pigneux, Arnaud, Tavitian, Suzanne, Kramer, Michael, Serve, Hubert, Bornhäuser, Martin, Platzbecker, Uwe, Müller-Tidow, Carsten, Baldus, Claudia D., Martínez-Cuadrón, David, Serrano, Josefina, Martínez-Sánchez, Pilar, Arbolí, Eduardo Rodríguez, Gil, Cristina, Bergua, Juan, Bernal, Teresa, de la Fuente Burguera, Adolfo, Delabesse, Eric, Bidet, Audrey, Dumas, Pierre-Yves, Montesinos, Pau, Récher, Christian
Publicado 2022